Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Clinical trial NCT05683951 · COMPLETED

Trial details

NCT number: NCT05683951
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Infection

Start date: 2021-11-26
Primary completion: 2022-12-09
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.